[Replay] EADV 2026 - Facial Eczema: When a Visible Disease Becomes a Daily Burden
Wrap up
Part 1 - The Invisible Impact of a Highly Visible Disease
14 min
Dr. B. HALIOUA
Dermatologist, France
Part 2 - A Therapeutic Challenge and the Role of Supportive Dermocosmetic Care
18 min
Pr. C. VESTERGAARD
Dermatologist, Denmark
Part 3 - Questions and answers
3 min
Dr. B. HALIOUA
Dermatologist, France
Pr. C. VESTERGAARD
Dermatologist, Denmark
Discover the scientific posters associated with this pathology
EADV2026_Tolerance and efficacy of a new emollient eyelid balm containing Rhealba oat and Helichrysum g. in eyelid eczema
.PDF 0.89 Mo
EADV2026_Multidimensional evaluation of an emollient with Rhealba oat and Helichrysum g. in adult AD
.PDF 0.67 Mo
EADV2026_New Rhealba Oat & Helichrysum g. Facial Emollient in Long-Term Atopic Dermatitis - An Open-Label Study
.PDF 0.93 Mo
EADV2026_Emollient containing Rhealba oat and Helichrysum g. in combination with tacrolimus in patients with eyelid AD
.PDF 1.24 Mo
EADV2026_Benefits of an emollient with Rhealba Oat and Helichrysum g. on AD in skin of color
.PDF 1.53 Mo
Interested in our news?
Discover those of our other brands.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.